169808-01-9

Basic information

• Product Name: [(R,S)-4-(4-cyanophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetic acid methyl ester
• Synonyms: [(R,S)-4-(4-cyanophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetic acid methyl ester
• CAS NO: 169808-01-9
• Molecular Weight: 287.275
• Mol File: 169808-01-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: [(R,S)-4-(4-cyanophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [(R,S)-4-(4-cyanophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetic acid methyl ester(169808-01-9)
• EPA Substance Registry System: [(R,S)-4-(4-cyanophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetic acid methyl ester(169808-01-9)

Safety Data

• Hazardous Substances Data: 169808-01-9(Hazardous Substances Data)

Upstream product

• 1443-80-7 4-cyanophenyl methyl ketone 
• 96-34-4 methyl chloroacetate 
• 169808-00-8 4-(R,S)-(4-cyanophenyl)-4-methyl-2,5-dioxoimidazolidine 

Downstream Products

• 207604-18-0 methyl ((R,S)-4-(4-cyanophenyl)-3-benzyl-4-methyl-2,5-dioxoimidazolidin-1-yl)acetate 
• 169808-04-2 methyl ((R,S)-4-(4-cyanophenyl)-3,4-dimethyl-2,5-dioxoimidazolidin-1-yl)acetate 
• 169808-22-4 {2-[4-(R,S)-(4-tert-butoxycarbonylaminomethyl-phenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetyl}-Asp(O-t-Bu)-(S)-phenylglycine-O-t-Bu 
• 762217-10-7 N-(tert-butoxycarbonyl-phenyl-methyl)-3-{2-[4-(4-carbamimidoyl-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl]-acetylamino}-succinamic acid tert-butyl ester 
• 736115-77-8 2-benzyloxycarbonylamino-3-{2-[4-(4-carbamimidoyl-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl]-acetylamino}-propionic acid tert-butyl ester 

Relevant articles and documents

Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists

The present invention relates to compounds of the formula I which are inhibitors of the adhesion and migration of leucocytes and/or antagonists of the adhesion receptor VLA-4 which belongs to the group of integrins. The invention also relates to processes

Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists

Compounds of the formula I, in which B, E, W, Y, Z, R, R2, R2a, R2b, R3, g and h have the meanings indicated in the specifications. The compounds of the formula I are valuable pharmaceutical active compounds, which are suitable, for example, for the thera